Back
Cormedix Vs. Outlook Therapeutics Industry Stock Comparison
Sell
31
CRMD
Cormedix
Last Price:
9.60
Seasonality Move:
34.02%
Sell
38
OTLK
Outlook Therapeutics
Last Price:
6.06
Seasonality Move:
-9.79%
Sell
31
Cormedix (CRMD)
is a Sell
Is Cormedix a Buy, Sell or Hold?
- The current Cormedix [CRMD] share price is $9.59. The Score for CRMD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CRMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $6.04. The Score for OTLK is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRMD Stock Price Chart
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $6.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OTLK is experiencing slight selling pressure.
CRMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 44.66 | Sell |
| Chaikin Money Flow: | -1221276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.8 - 11.94) | Sell |
| Bollinger Bands (100): | (3.94 - 9.08) | Buy |
OTLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 60.41 | Buy |
| Chaikin Money Flow: | -67113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.08 - 5.7) | Buy |
| Bollinger Bands (100): | (5.76 - 7.98) | Sell |
CRMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.47 | Sell |
| 20-day SMA: | 10.88 | Sell |
| 50-day SMA: | 8.52 | Buy |
| 200-day SMA: | 5.44 | Buy |
| 8-day EMA: | 10.78 | Sell |
| 20-day EMA: | 10.55 | Sell |
| 50-day EMA: | 8.94 | Buy |
| 200-day EMA: | 6.13 | Buy |
OTLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.74 | Buy |
| 20-day SMA: | 5.42 | Buy |
| 50-day SMA: | 6.06 | Sell |
| 200-day SMA: | 7.53 | Sell |
| 8-day EMA: | 5.78 | Buy |
| 20-day EMA: | 5.64 | Buy |
| 50-day EMA: | 6 | Buy |
| 200-day EMA: | 8.13 | Sell |
Cormedix Earnings Growth & CRMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.97 per share.
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
Cormedix Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Outlook Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||